Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of EUR 282.01 billion. The enterprise value is 292.25 billion.
Market Cap | 282.01B |
Enterprise Value | 292.25B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.71% |
Shares Change (QoQ) | -0.11% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.18B |
Valuation Ratios
The trailing PE ratio is 20.83.
PE Ratio | 20.83 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 64.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 29.53.
EV / Earnings | 21.58 |
EV / Sales | 7.51 |
EV / EBITDA | 14.72 |
EV / EBIT | 15.59 |
EV / FCF | 29.53 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.
Current Ratio | 0.74 |
Quick Ratio | 0.52 |
Debt / Equity | 0.72 |
Debt / EBITDA | 0.69 |
Debt / FCF | 1.39 |
Interest Coverage | 85.29 |
Financial Efficiency
Return on equity (ROE) is 80.78% and return on invested capital (ROIC) is 46.03%.
Return on Equity (ROE) | 80.78% |
Return on Assets (ROA) | 22.41% |
Return on Invested Capital (ROIC) | 46.03% |
Return on Capital Employed (ROCE) | 56.34% |
Revenue Per Employee | 506,855 |
Profits Per Employee | 176,260 |
Employee Count | 77,349 |
Asset Turnover | 0.74 |
Inventory Turnover | 1.20 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.70% in the last 52 weeks. The beta is 0.17, so Novo Nordisk's price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | -47.70% |
50-Day Moving Average | 77.87 |
200-Day Moving Average | 102.63 |
Relative Strength Index (RSI) | 24.49 |
Average Volume (20 Days) | 157,531 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of EUR 38.94 billion and earned 13.54 billion in profits. Earnings per share was 3.03.
Revenue | 38.94B |
Gross Profit | 33.10B |
Operating Income | 18.76B |
Pretax Income | 17.05B |
Net Income | 13.54B |
EBITDA | 19.67B |
EBIT | 18.76B |
Earnings Per Share (EPS) | 3.03 |
Balance Sheet
The company has 3.53 billion in cash and 13.78 billion in debt, giving a net cash position of -10.25 billion.
Cash & Cash Equivalents | 3.53B |
Total Debt | 13.78B |
Net Cash | -10.25B |
Net Cash Per Share | n/a |
Equity (Book Value) | 19.24B |
Book Value Per Share | 4.33 |
Working Capital | -7.59B |
Cash Flow
In the last 12 months, operating cash flow was 16.22 billion and capital expenditures -6.32 billion, giving a free cash flow of 9.90 billion.
Operating Cash Flow | 16.22B |
Capital Expenditures | -6.32B |
Free Cash Flow | 9.90B |
FCF Per Share | n/a |
Margins
Gross margin is 85.00%, with operating and profit margins of 48.17% and 34.78%.
Gross Margin | 85.00% |
Operating Margin | 48.17% |
Pretax Margin | 43.80% |
Profit Margin | 34.78% |
EBITDA Margin | 50.51% |
EBIT Margin | 48.17% |
FCF Margin | 25.41% |
Dividends & Yields
This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 2.40%.
Dividend Per Share | 1.53 |
Dividend Yield | 2.40% |
Dividend Growth (YoY) | 21.20% |
Years of Dividend Growth | 5 |
Payout Ratio | 43.71% |
Buyback Yield | 0.71% |
Shareholder Yield | 3.10% |
Earnings Yield | 4.80% |
FCF Yield | 3.51% |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
Last Split Date | Sep 13, 2023 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 8.94.
Altman Z-Score | 8.94 |
Piotroski F-Score | n/a |